Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 3-bromo-4-chloro-, ethyl ester is a chemical compound with the molecular formula C9H8BrClO2. It is an ester of benzoic acid, containing both bromine and chlorine atoms. Benzoic acid, 3-bromo-4-chloro-, ethyl ester is known for its pleasant aroma and taste, making it a valuable ingredient in various applications.

76008-75-8

Post Buying Request

76008-75-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76008-75-8 Usage

Uses

Used in Food and Beverage Industry:
Benzoic acid, 3-bromo-4-chloro-, ethyl ester is used as a flavoring agent for its pleasant aroma and taste, enhancing the sensory experience of food and beverages.
Used in Cosmetics and Personal Care Products:
In the cosmetics and personal care industry, Benzoic acid, 3-bromo-4-chloro-, ethyl ester serves as a preservative, helping to maintain the freshness and shelf life of products by preventing microbial growth.
Used in Pharmaceutical Industry:
Benzoic acid, 3-bromo-4-chloro-, ethyl ester has potential applications in the pharmaceutical industry, particularly in the synthesis of pharmaceutical intermediates, contributing to the development of new medications.
It is important to handle Benzoic acid, 3-bromo-4-chloro-, ethyl ester with care, as it can be irritating to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use and handling to minimize potential adverse effects.

Check Digit Verification of cas no

The CAS Registry Mumber 76008-75-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,0,0 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 76008-75:
(7*7)+(6*6)+(5*0)+(4*0)+(3*8)+(2*7)+(1*5)=128
128 % 10 = 8
So 76008-75-8 is a valid CAS Registry Number.

76008-75-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3-bromo-4-chlorobenzoate

1.2 Other means of identification

Product number -
Other names 3-Bromo-4-chloro-benzoic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76008-75-8 SDS

76008-75-8Relevant academic research and scientific papers

A convergent strategy towards febrifugine and related compounds

Maiden,Mbelesi,Procopiou,Swanson,Harrity

, p. 4159 - 4169 (2018/06/12)

We report a modular five step synthetic route to the febrifugines that employs 2-(chloromethyl)allyl-trimethylsilane as a conjunctive reagent for the coupling of the piperidine and quinazolinone groups. We also demonstrate the application of a recent Rh-catalyzed quinazolinone synthesis for the facile generation of febrifugine analogs.

Regioselective synthesis of benzimidazolones via cascade C-N coupling of monosubstituted ureas

Ernst, Johannes B.,Tay, Nicholas E. S.,Jui, Nathan T.,Buchwald, Stephen L.

supporting information, p. 3844 - 3846 (2014/08/05)

A direct method for the regioselective construction of benzimidazolones is reported wherein a single palladium catalyst is employed to couple monosubstituted urea substrates with differentially substituted 1,2-dihaloaromatic systems. In this method, the catalyst is able to promote a cascade of two discrete chemoselective C-N bond-forming processes that allows the highly selective and predictable formation of complex heterocycles from simple, readily available starting materials.

INDAZOLE DERIVATIVES THAT INHIBIT TRPV1 AND USES THEREOF

-

Page/Page column 34, (2008/06/13)

Compounds of formula (I) wherein R3, R7, R9 and L are defined in the description are TRPV1 antagonists that exhibit low inhibitory activity against CYP3A4. Compositions comprising such compounds and methods for treating co

Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia

-

, (2008/06/13)

The present invention relates to compounds of Formula (I) which may be useful in the treatment of diseases, such as, metabolic disorders, dyslipidemia and/or hyperchloesterolemia: 1

Heterocyclic derivatives for the treatment of diabetes and other diseases

-

, (2008/06/13)

The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.

Use of Potassium Bromate: Bromination of Halobenzenes and Halobenzoic Acids

Banerjee, Amalendu,Banerjee, Gopal Chandra,Dutt, Sachchidananda,Banerjee, Santa (Mrs.),Samaddar, Haraprasad

, p. 640 - 642 (2007/10/02)

Syntheses of bromo compounds by the bromination of halobenzenes and halobenzoic acids using potassium bromate under acidic condition have been discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 76008-75-8